News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Yianni Kournoutas: 1st Line Atezolizumab/Bevacizumab vs. Tremelimumab/Durvalumab in Unresectable HCC
medicinetoday.com
Jan 27, 2025, 10:10

Yianni Kournoutas: 1st Line Atezolizumab/Bevacizumab vs. Tremelimumab/Durvalumab in Unresectable HCC

Yianni Kournoutas, Hematologist and Oncologist at Mayo Clinic shared a post on X:

“Great time at GI25, GIASCO so far! Had a blast presenting our study on 1st line atezo/bev vs. treme/durva in unresectable HCC.

Many thanks to my mentors Dr. Tran Nguyen and Dr. Ou for their support and guidance.”

Yianni Kournoutas: 1st Line Atezolizumab/Bevacizumab vs. Tremelimumab/Durvalumab in Unresectable HCC

cancer OncoDaily Oncology Ou Tran Nguyen Yianni Kournoutas
Special Coverage
Career
Jun 4, 2025, 17:30
Fellowship and Short-Term Training Opportunities Now Open at POEM Training Centers - POEM Group
Celebrities
Jun 4, 2025, 17:16
Jessie J Diagnosed with Early-Stage Breast Cancer: What Is the Prognosis?
Blog
Jun 4, 2025, 17:13
Katy Rezvani Has Been Appointed as AACR 2026 Program Committee Co-Chair and Elected to the Association of American Physicians
Blog
Jun 4, 2025, 17:07
Teresa Amaral: The Fantastic Faculty of The ASCO and ESMO Session at ASCO25 Congress
Blog
Jun 4, 2025, 17:02
Jennifer Buell Highlights Strategic Partnership Between Agenus and Zydus
Blog
Jun 4, 2025, 16:52
Olubukola Ayodele: I Leave ASCO25 Feeling Recharged Not Just By Data But By Direction
Insight
Jun 4, 2025, 16:33
Paolo Tarantino on Sara Tolaney’s Leadership and Mentorship at ASCO 2025
Blog
Jun 4, 2025, 16:33
Maryam Lustberg: Grateful For My MASCC Family
Insight
Jun 4, 2025, 16:30
Jasmine Kamboj Celebrated ASCO Advocacy Award with Team Minnesota at ASCO 2025
Blog
Jun 4, 2025, 16:27
Hadieh Eslampanah: Happy International Cancer Survivors Day 2025 - New Life and New Beginning
Oncolibrary
Jun 4, 2025, 16:20
IMMUNOSARC II Study Results: Sunitinib Plus Nivolumab Shows Promising Activity in Advanced Extraskeletal Myxoid Chondrosarcoma (EMC)
Blog
Jun 4, 2025, 15:56
SIOG Announces Interactive Geriatric Assessment Workshop for SIOG 2025